Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS)

M Ojeda-Ojeda, M Murri, M Insenser… - Current …, 2013 - ingentaconnect.com
Chronic low-grade subclinical inflammation has been increasingly recognized as an
interposer in the endocrine, metabolic and reproductive disturbances that characterize the …

Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome

S Palomba, T Russo, A Falbo, A Di Cello… - Human …, 2013 - academic.oup.com
STUDY QUESTION Do patients with polycystic ovary syndrome (PCOS) have macroscopic
and/or microscopic placental alterations? SUMMARY ANSWER The placental structure in …

Is interleukin‐17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?

Ö Özçaka, N Buduneli, BO Ceyhan… - Journal of …, 2013 - Wiley Online Library
Background: Polycystic ovarian syndrome (PCOS) is a hormonal disorder of females of
reproductive age that impacts their oral and systemic health. The aim of this study is to …

Risks for gestational diabetes mellitus and pregnancy‐induced hypertension are increased in polycystic ovary syndrome

Y Wang, X Zhao, H Zhao, H Ding, J Tan… - BioMed research …, 2013 - Wiley Online Library
Objectives. To evaluate pregnancy outcomes and its determinants in women with polycystic
ovary syndrome (PCOS). Methods. Two‐hundred and twenty pregnant PCOS and 594 …

Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance

N Phelan, A O'Connor, T Kyaw Tun… - Clinical …, 2013 - Wiley Online Library
Objectives Low‐grade chronic inflammation predicts cardiovascular outcomes and is
observed in women with polycystic ovary syndrome (PCOS). Whether this is entirely a cause …

Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome

A Harmanci, N Cinar, M Bayraktar… - Clinical …, 2013 - Wiley Online Library
Objective Oral contraceptives alone or in combination with antiandrogens are commonly
used in the treatment for polycystic ovary syndrome (PCOS). We aimed to determine the …

Effect of M etformin compared with hypocaloric diet on serum C‐reactive protein level and insulin resistance in obese and overweight women with polycystic ovary …

F Esfahanian, MM Zamani, R Heshmat… - Journal of Obstetrics …, 2013 - Wiley Online Library
Aim The aim of the present study was to investigate the efficacy of M etformin compared with
a hypocaloric diet on C‐reactive protein (CRP) level and markers of insulin resistance in …

Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?

E Rey-Roldan, MB Perez Lana, L Galluzzo… - Gynecological …, 2013 - Taylor & Francis
Aims: To investigate the relationship between the levels of C-reactive protein (CRP),
interleukin-6 (IL-6) and IL-1β and the hormonal and metabolic alterations in women with …

Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome?

E Gözdemir, I Kaygusuz, H Kafalı - Gynecologic and obstetric …, 2013 - karger.com
Abstract Background/Aims: Polycystic ovary syndrome (PCOS) is associated with
reproductive and metabolic abnormalities and carries a number of cardiovascular risk …

[PDF][PDF] İnfertilite polikliniğine başvuran kadın hastaların sosyodemografik özelliklerinin değerlendirilmesi

S Haliloğlu, ZA Sağlam, D Toprak… - Smyrna Tıp Dergisi, 2013 - smyrnatipdergisi.com
Objective: In this study, sociodemographic features and comorbid diseases were evaluated
retrospectively in patients who applied to infertility policlinic for any reason. Materials and …